Beruflich Dokumente
Kultur Dokumente
and
Strategic Treatment
Presented by:
Komal Padhariya
(T.Y.B.Pharm)
Guided by:
Mrs. Sugandha
C.
Anatomy of breast
Breast profile:
A Ducts
B Lobules
C Dilated section of duct to
hold milk
D Nipple
E Fat
F Pectoralis major muscle
G Chest wall/rib cage
Enlargement:
A Normal duct cells
B Basement membrane
C Lumen (center of duct)
Interior of breast
The breast is
composed of glandular
and adipose tissue in
varying proportions.
The glandular tissue
consists of 15–20
lobes containing
numerous lobules,
linked by ductules.
The latter combine to
form the lactiferous
ducts
Blood supply to breast
Anatomy of the breast, showing
lymph nodes
Each breast also
has blood vessels
and lymph vessels.
Lymph vessels lead
to organs called
lymph nodes.
Lymph node filters
substances in
lymph and helps
fight infection and
Breast cancer:
Breast cancer is a disease in which malig
Age and health history can affect the
risk of developing breast cancer.
Breast cancer is sometimes caused
by inherited gene mutations
(changes).
Certain factors affect prognosis
(chance of recovery) and treatment
options.
TYPES OF BREAST CANCER
BREAST
CANCER
1. DUCTAL 2. LOBULAR
CARCINOMA CARCINOMA 1. SOLID 2. CRIBIFORM
INSITU INSITU
3. INVASIVE 4. INVASIVE
DUCTAL LOBULAR 3. PAPILLARY 4. COMEDO
CARCINOMA CARCINOMA
NON INVASIVE & INVASIVE DCIS & LCIS
Lobular Carcinoma Invasive Lobular
Ductal Carcinoma Invasive
in situ (LCIS) Carcinoma
in situ (DCIS) Ductal Carcinoma (IDC)
(ILC)
• Incisional biopsy
• Core biopsy
• Needle biopsy
• Estrogen &
progesterone receptor test
STAGES OF BREAST CANCER
Staging is the process physicians use to asses the size and
location of patients cancer
To stage cancer, cancer are designated the letter T(Tumor
size),N(Palpable nodes) and M(metastatis)
Numerical Stages of Breast Cancer
The stage of a breast cancer describes its size and the extent to which it. has
spread. The staging system ranges from Stage 0 to Stage IV
I Less than 2 cm No No
II Between 2-5 cm No or in same side of breast No
III More than 5 cm Yes, on same side of breast No
IV Not applicable Not applicable Yes
Stage Definition
Stage 0 Cancer cells remain inside the breast duct,
without invasion into normal adjacent breast
tissue
Woman in position for radiation treatment, from the side. Side radiation
treatment beam is shown
A Bright yellow: breast being treated
B Light yellow: beam in air, not touching woman
C Opening of the linear accelerator
D Arm holder
Selective estrogen-
receptor modulator
(SERM)
eg.Tamoxifen, Raloxifene,
Toremifene
Aromatase inhibitors
• Arimidex
• Aromasin
• Femara
2.SIGNALING OF
THE IMMUNE
SYSTEM
3. WORKING WITH
CHEMOTHERAPY
MECHANISM OF ACTION
Two tests are used to figure out if the
cancer is likely to respond to Herceptin
• Test used to see if a tumor has too much of the HER 2 receptor protein
on the surface of the cancer cells
• Gives a score of 0 to 3+ that indicates the amount of HER 2 receptor
protein in the tumors
• If the tumor scores 0 to 1+ called “HER 2 negative”.
• If the tumor scores 2+ or 3+ called “HER 2 positive”
• Women with IHC positive respond favourably to herceptin
• Drug is not considered effective for tumors with IHC scores of 0and 1+
FORMULA :
patient weight in kg x = ml of
Herceptin reconstituted
solution
ADMINISTRATION
Given intravenously
Given once a week or once every
three weeks
4mg/kg loading dose administered
over a 90 min infusion
2 mg/kg maintaince dose
administered as a 30 min infusion
DO NOT ADMINISTER as IV PUSH OR
BOLUS
Herceptin should not mixed or
diluted with other drugs
SIDE EFFECTS OF HERCEPTIN
EARLY EFFECTS
Fever and sweating
Chills
Skin flushing – redness
Discomfort in the throat
Difficulty in breathing
ONGOING EFFECTS
Weakness , tiredness
Headache
Sore eyes
Joint pain
Diarrhea
LATE SIDE EFFECTS
Heart problems
Allergic like reactions
Lung reactions
HERCEPTIN AND CHEMOTHERAPY
Herceptin is often given in combination with
other cancer drugs.
Some of the chemotherapy drugs that has
been given with Herceptin includes
Taxol
Navelbine
Xeloda
Paraplatin
Chemotherapy drugs are given intravenously
on the same weekly schedule as Herceptin
Studies revealed that , women with metastatic
disease got better results when they took
Herceptin with chemotherapy drugs
CONCLUSION:
A survey says that every one in 875
women and every one in 10,000 men
suffer from breast cancer worldwide. In
many cases it is found as small tumor
while in some the cancer spreads which
could be fatal.
Early detection can help us to avoid
serious damages caused by proliferation.
This can be possible by self examination
and with the help of the physician.
The treatments for curing breast
cancer are very expensive so
spending